AllCells’ on-site collection and processing facilities across the US provide the flexibility to meet unique customer requests outside the scope of our comprehensive research- and clinical-grade product portfolio. Our Made-to-Order team will work with you to meet special requests for tissue collection, cell processing, characterization and packaging.
Donor Management Services
AllCells’ Donor Management Teams contribute deep expertise. Paired with our comprehensive program, Donor Management helps you recruit, screen and retain donors with the attributes necessary to meet your program requirements at every stage of the cell therapy development continuum – from pre-clinical to commercialization.
Accurately enumerating CD34+ cells within a heterogeneous cell population is important because this small subset of cells is responsible for multilineage engraftment. The International Society of Hematotherapy and Graft Engineering (ISHAGE) established a standardized, four-parameter flow cytometric method followed by a sequential gating strategy to quantitate CD34+ cells in apheresis products, peripheral blood, and bone marrow used widely in research and clinical settings. Our CD34+ isolated cell products are assessed and quality-controlled using the standardized ISHAGE protocol to quantify viable CD34+ upon request.